News
Podcast
Author(s):
Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
ICYMI: FDA Approves Galderma's Nemolizumab for Moderate to Severe Atopic Dermatitis in Patients 12 and Older
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Arcutis Submits sNDA for Roflumilast Cream 0.05% to FDA for Patients Ages 2 to 5 with Atopic Dermatitis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Pediatric and Adult AD Cases Illuminate Benefits of Topical PDE4 Inhibitors
A Family-Centered Approach to Managing AD